Neurofibromatosis type-1 is a prognostic indicator in human gastric carcinoma.

about

Neurofibromatosis type-1 is a prognostic indicator in human gastric carcinoma.

Item

http://www.wikidata.org/entity/Q47172712

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Neurofibromatosis type-1 is a prognostic indicator in human gastric carcinoma.

@en

Neurofibromatosis type-1 is a prognostic indicator in human gastric carcinoma.

@nl

type

Item

label

Neurofibromatosis type-1 is a prognostic indicator in human gastric carcinoma.

@en

Neurofibromatosis type-1 is a prognostic indicator in human gastric carcinoma.

@nl

prefLabel

Neurofibromatosis type-1 is a prognostic indicator in human gastric carcinoma.

@en

Neurofibromatosis type-1 is a prognostic indicator in human gastric carcinoma.

@nl

P1476

Neurofibromatosis type-1 is a prognostic indicator in human gastric carcinoma.

@en

P2093

Debao Liu

http://www.w3.org/2001/XMLSchema#string

Kaixi Fan

http://www.w3.org/2001/XMLSchema#string

Yan Li

http://www.w3.org/2001/XMLSchema#string

Yueying Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Somatic mutations affect key pathways in lung adenocarcinoma

A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor

The neurofibromatosis type 1 gene encodes a protein related to GAP

Role of the PEBP4 protein in the development and metastasis of gastric cancer.

Reduced NF1 expression confers resistance to EGFR inhibition in lung cancer

The NF1 gene revisited - from bench to bedside.

Loss of NF1 expression in human endothelial cells promotes autonomous proliferation and altered vascular morphogenesis.

Early-Onset Breast Cancer in a Family with Neurofibromatosis Type 1 Associated with a Germline Mutation in BRCA1

NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer

Metabolic Tumour Burden Measured by 18F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1.

P304

82910-82919

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.19876

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29137312

http://www.w3.org/2001/XMLSchema#string

P932

5669938

http://www.w3.org/2001/XMLSchema#string